Was AK correct that the quantum age is nigh?
https://www.barrons.com/articles/quantum-ibm-cleveland-clinic-dr-gs-35cf1909
By: Mackenzie Tatananni |
Updated May 05, 2026, 12:08 pm EDT / Original May 05, 2026, 12:01 am EDT
As investors await a quantum revolution, researchers are already delivering the first tremors.Look
no further than the latest study from International Business Machines,
conducted alongside Riken and Cleveland Clinic. Scientists linked IBM quantum systems
to two of the world’s most powerful supercomputers: Fugaku at Riken and
Miyabi-G, operated by the University of Tokyo and the University of
Tsukuba.The end
result was a protein complex spanning more than 12,000 atoms. While
highly technical, the demonstration has clear applications in dr-g
discovery and medicine, potentially delivering the transformation that
quantum enthusiasts have long promised.“They’re
the largest known molecules to be simulated thus far with quantum
computing,” Jerry Chow, IBM’s chief technology officer of
quantum-centric computing, said ahead of the announcement.He
is describing what IBM and Cleveland Clinic define as “biologically
meaningful molecules.” The protein simulated in this case is called
trypsin, a heavyweight in the world of biology. Without it, the body
would struggle to perform one of its most basic functions: breaking down
proteins into the building blocks it needs to survive.A lot of quantum research
has centered on this type of work, which has clear applications in dr-g
development. However, investors have been eager for results that prove
quantum computers are useful for something other than lab-scale
demonstrations.“The
hook here is that we want to go to a world where we have much better
therapeutics and things that make all of our lives better,” Chow
explained. “Fundamentally core to that is understanding how molecules
behave, how molecules interact with things such as water. In many ways,
this is the largest demonstration to date.”Kenneth
Merz, the lead author of the study, agrees. “I always go to the dr-g
discovery angle,” Merz said. “We’re developing methods to discover dr-gs
to improve human health. But there’s also this concept of divide and
conquer.”Merz, a
staff scientist at Cleveland Clinic, leads a lab dedicated to building
computational tools that apply theoretical math to biological research.
The latest experiment shows how existing hardware can be paired with
quantum machines to solve problems that today’s computers cannot handle
alone, he said.“You
take a very big problem and break it into small pieces that are able to
run on current-generation hardware, and then stitch it together to get
the global answer,” Merz explained.The team stopped short of claiming quantum advantage, a milestone many investors are watching closely.Quantum
advantage refers to a system’s ability to outperform classical
computers at a range of tasks, doing so more efficiently, accurately,
and inexpensively. While often viewed as the true tipping point for the
technology, focusing solely on this milestone risks overlooking the
incremental progress made along the way.Chow
emphasized that any claim of quantum advantage must be validated
against established, rigorous testing frameworks. The scientific
community isn’t there yet, and to date, there is no consensus whether or
not true advantage has been achieved.“What
we’re seeing is this groundswell of pushing the envelope of what can be
done,” Chow continued. “We’re using these machines and these
capabilities to look in these areas where we know classical methods will
struggle.”He views
the latest study as part of a larger puzzle. “It’s not a singular moment
in time for quantum advantage,” Chow said. “But we’re certainly in this
phase where we’re absolutely using these machines to do real exciting
work.”